Concurrent Conditions and Human Listeriosis, England, 1999–2009 by Mook, Piers et al.
The epidemiology of listeriosis in England and Wales 
changed during 2001–2008; more patients >60 years of 
age had bacteremia than in previous years. To investigate 
these changes, we calculated risk for listeriosis by concur-
rent condition for non–pregnancy-associated listeriosis cas-
es reported to the national surveillance system in England 
during 1999–2009. Conditions occurring with L. monocyto-
genes infection were coded according to the International 
Classiﬁ   cation of Diseases, 10th Revision, and compared 
with appropriate hospital episode statistics inpatient de-
nominator data to calculate incidence rates/million con-
sultations. Malignancies (especially of the blood), kidney 
disease, liver disease, diabetes, alcoholism, and age >60 
years were associated with an increased risk for listeriosis. 
Physicians should consider a diagnosis of listeriosis when 
treating patients who have concurrent conditions. Providing 
cancer patients, who accounted for one third of cases, with 
food safety information might help limit additional cases.
L
isteriosis is a rare but serious foodborne disease caused 
by the bacterium Listeria monocytogenes. Three groups 
of persons are disproportionately affected: the elderly, the 
immunocompromised, and pregnant women and their un-
born or newborn infants. The clinical signs of disease in 
these persons include septicemia, meningitis, and miscar-
riage. Pregnant women can transmit the infection to the 
fetus, for whom the result can be deadly. However, these 
women may not have clearly overt signs or symptoms of 
infection. Case-fatality rates range from 20% to 50% (1). 
The susceptibility of healthy persons to symptomatic list-
eriosis is substantially less than that of persons with under-
lying conditions.
Persons with cancer, diabetes, AIDS, and liver or kid-
ney disease are often predisposed to severe infection and 
death after infection with L. monocytogenes. This predis-
position is a consequence of suppressed T-cell–mediated 
immunity (2) caused by the condition or its treatment. 
Similarly, pregnant women, the elderly, and those receiv-
ing immunosuppressive therapy are also at risk because of 
impaired or modulated immune function.
The epidemiology of listeriosis in England and Wales 
has changed since 2001 (3). Incidence has increased (2.1 
cases/million population during 1990–2000 vs. 3.6 cases/
million population during 2001–2009), and more cases have 
been found in persons >60 years of age who had bacteremia 
(but not meningitis). Similar patterns have been reported 
in other countries in Europe (4–6). The reasons for these 
changes are not fully understood, but they do not seem to 
be caused by surveillance artifacts and are not associated 
with sex, season, geography, ethnic or socioeconomic dif-
ferences, underlying conditions, or L. monocytogenes sub-
type (3). We have showed that the increase occurred in 
persons with cancer or other conditions whose treatment 
included acid-suppressing medication (7). In view of recent 
trends, we examined national surveillance data for England 
to quantify the role of concurrent conditions in persons 
with listeriosis and stratiﬁ  ed these conditions to examine 
risks for persons >60 years of age.
Methods
The Health Protection Agency Centre for Infections 
has coordinated national surveillance of listeriosis in Eng-
land and Wales since 1990. Cases are included in the system 
by voluntary referral of cultures to the national reference 
laboratory or by electronic reporting of conﬁ  rmed cases 
from local laboratories. Clinical data, including details of 
patients’ concurrent conditions, are subsequently sought 
from the consultant clinical microbiologist involved in the 
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care of the case-patient. Microbiologic data from local and 
reference laboratories and clinical and risk factor data are 
linked for each case, deduplicated as necessary, and stored 
in a bespoke Microsoft Access database (Microsoft, Red-
mond, WA, USA) Access database.
A case of listeriosis is deﬁ  ned as a person with clini-
cally compatible illness and from whom L. monocytogenes 
was isolated from a normally sterile site. Cases are sub-
sequently classiﬁ   ed as either non–pregnancy-associated 
(persons >1 month of age) or pregnancy-associated (a 
maternal–fetal or maternal–neonatal pair; such pairs were 
considered a single case). In this study, we included non–
pregnancy-associated cases reported from laboratories in 
England for which a clinical questionnaire was available 
and showed that at least 1 reported concurrent condition 
was present. We included cases reported during April 1, 
1999–March 31, 2009 because denominator data were ar-
ranged by ﬁ  scal years. These cases included sporadic cases 
and cases that were identiﬁ  ed as being part of common 
source foodborne outbreaks.
Authors (P.M. and I.A.G.) reviewed each reported 
concurrent condition and assigned an International Clas-
siﬁ  cation of Diseases, 10th Revision (ICD-10) (8) code 
when appropriate. Rules for assigning codes were devel-
oped at the outset to ensure standardized coding throughout 
the study (online Technical Appendix, www.cdc.gov/EID/
content/17/1/38-Techapp.pdf). These rules were validated 
by a third author (S.J.O.), a clinically qualiﬁ  ed investiga-
tor, who also reviewed any coding disparities. Counts were 
calculated of all persons and those >60 years of age for 
each ICD-10 chapter (ICD-10 codes are aggregated into 22 
chapters) and subgroup (within each chapter).
Hospital episode statistics ﬁ   nished consultant epi-
sodes (FCE) data, which were aggregated by ICD-10 
code, age group (0–14 years, 15–59 years, 60–74 years, 
and >75 years), and ﬁ  scal year, were obtained from the 
Health and Social Care Information Centre (9) and used 
as denominator data. These data describe episodes of con-
tinuous admitted patient care under a speciﬁ  c consultant 
for National Health Service hospital inpatients in Eng-
land, and a primary diagnosis is assigned to each episode 
by using ICD-10 coding. To ensure reliable conﬁ  dence in-
tervals (CIs), we calculated incidence rates/million FCEs 
and 95% CIs for each ICD-10 chapter and subgroup in 
which there were >10 cases. Two ICD-10 chapters not 
used by hospital episodes statistics to code primary diag-
noses, external causes of morbidity and mortality (V01–
Y98) and codes for special purposes (U00–U99), were not 
considered. Relative risks (RRs) and corresponding 95% 
CIs were calculated as appropriate when >10 cases were 
reported for a concurrent condition subgroup or chapter. 
Analysis was then repeated for case-patients >60 years 
of age.
Data were stored, manipulated, and summarized by us-
ing Microsoft Access, and incidence rates and RRs were 
calculated by using Microsoft Excel. Differences in propor-
tions and changes in proportions over strata were assessed 
by using the χ2 test and the χ2 test for trend, respectively.
Results
A total of 1,239 ICD-10–coded concurrent conditions 
were reported by 1,413 case-patients with non–pregnancy-
associated listeriosis in England during April 1, 1999–
March 31, 2009 (Figure). Of those patients who reported 
>1 underlying condition, 21 (2.2%) were identiﬁ  ed as be-
ing part of a common source outbreak. Characteristics of 
case-patients with and without a completed clinical ques-
tionnaire are shown in Table 1. Overall, 9.1 cases of list-
eriosis/million FCEs were reported over the study period 
(95% CI 8.6–9.6) (online Appendix Table, www.cdc.gov/
EID/content/17/2/38-appT.htm). Compared with all other 
reported conditions, higher rates of disease were reported 
for the following chapters (in order of highest to lowest 
RR): endocrine, nutritional, and metabolic diseases (RR 
5.3, 95% CI 4.2–6.6); neoplasms (RR 4.9, 95% CI 4.4–
5.5); mental and behavior disorders (RR 3.1, 95% CI 2.4–
4.1); diseases of the circulatory system (RR 1.4, 95% CI 
1.2–1.6); diseases of the digestive system (RR 1.3, 95% CI 
1.1–1.5); and diseases of the musculoskeletal system and 
connective tissue (RR 1.3, 95% CI 1.1–1.6) (Table 2).
Within these chapters, only certain subgroups showed 
increased rates: diabetes mellitus; malignant neoplasms of 
the lymphoid, hematopoietic, and related tissues; eye, brain, 
and other parts of the central nervous system (CNS); respi-
ratory and intrathoracic organs; digestive organs; breast; 
male and female genital organs; thyroid and other endo-
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Figure. Study population and reported International Classiﬁ  cation 
of Diseases, 10th Revision (ICD-10)–coded concurrent conditions 
for 1,413 case-patients with non–pregnancy-associated listeriosis, 
England, April 1, 1999–March 31, 2009.RESEARCH
crine glands; mental and behavior disorders caused by psy-
choactive substances (alcohol-related in 96% of reports); 
hypertensive diseases, other forms of heart disease, and 
diseases of arteries, arterioles, and capillaries; diseases of 
the liver and noninfective enteritis and colitis; and systemic 
connective tissue disorders (Table 2). In addition, several 
subgroups were associated with increased risk even when 
the corresponding chapter was not: renal failure, diseases 
of blood and blood-forming organs, and chronic lower re-
spiratory diseases (Table 2).
Concurrent conditions were disproportionately report-
ed for persons >60 years of age (χ2 p<0.001), and the rate 
of listeriosis for this age group (16.8/million; 95% CI 15.8–
17.9) was signiﬁ  cantly higher than that for younger persons 
(RR 4.6, 95% CI 4.1–5.3) (Table 2). When the RR for each 
chapter for persons >60 years of age (using persons <60 
years of age as the reference population) was calculated, the 
following were associated with increased risk: endocrine, 
nutritional and metabolic diseases; genitourinary system 
diseases; diseases of the musculoskeletal system and con-
nective tissue; neoplasms; certain infectious and parasitic 
diseases; diseases of the digestive system; and mental and 
behavior disorders (Table 2). In instances where the risk 
for each subgroup in persons >60 years of age could be 
calculated and compared with that for persons <60 years 
of age, all subgroups of previously identiﬁ  ed chapters were 
associated with increased risk.
Discussion
We analyzed surveillance data that included detailed 
denominator data by using an internationally recognized 
diagnostic classiﬁ  cation system and found that a wide vari-
ety of conditions seem to increase the risk for serious infec-
tion with L. monocytogenes. Malignancies accounted for 
more than one third of conditions, and cancer patients had 
a 5-fold increased risk for development of listeriosis. Can-
cers of the blood seemed to have the greatest effect. Other 
high-risk conditions included diabetes mellitus; alcohol-
ism; certain diseases of the circulatory system and the mus-
culoskeletal system and connective tissue; noninfective en-
teritis and colitis; and diseases of the liver and kidney. For 
most high-risk conditions, the risk for infection was higher 
among older patients.
Case identiﬁ  ed by the national surveillance program 
in England are laboratory conﬁ  rmed, and most cases result 
in serious illness requiring hospitalization or death. Given 
this ﬁ  nding, a hospitalized population better represents the 
population at risk than a community population, which was 
used in previous studies (10,11).
The response rate to the clinical questionnaire that 
captured information on concurrent conditions was high 
and not inﬂ  uenced by age or sex of the case-patient, which 
minimized differential ascertainment of clinical data. How-
ever, we could not assess concurrent conditions for which 
completed clinical questionnaires were not returned. This 
issue indicates that the role of some conditions might be 
underestimated if clinicians were unwilling to return ques-
tionnaires and disclose information for certain case-patients 
(e.g., those with AIDS). Similarly, but less likely, reporting 
bias might exist if the propensity to report certain concur-
rent conditions were affected by the presence or absence of 
others conditions, or if only concurrent conditions consid-
ered relevant to L. monocytogenes infection were reported. 
Concurrent conditions were reported by the clinical mi-
crobiologist rather than by the consultants responsible for 
the care of the patients with concurrent conditions. These 
consultants might be better informed of existing concurrent 
conditions. However, hospital microbiologists need to be 
aware of such conditions to provide treatment accordingly, 
and questioning several consultants for each case-patient 
may have a negative effect on questionnaire response be-
cause questionnaires might be lost if passed between mul-
tiple consultants.
Misclassiﬁ  cation was minimized by grouping condi-
tions only to 3-character ICD-10 code levels. Although 
we acknowledge that such grouping might mask high-risk 
conditions apparent at the 4-character ICD-10 code level, 
routine surveillance data were not speciﬁ  c enough to fur-
ther discriminate among conditions. In some instances, in 
which treatments were reported in the absence of relevant 
conditions (e.g., chemotherapy, dialysis, splenectomy), 
we made assumptions about the conditions requiring such 
treatment and coded accordingly (online Technical Ap-
pendix). Although these assumptions could inﬂ  ate the inci-
40  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011
Table 1. Characteristics of case-patients with non–pregnancy-
associated listeriosis, England, 1999–2009* 
Characteristic
No. (%) case-patients 
CQR,
n = 1,145 
No CQR,  
n = 268 
Fiscal years 
  1999–2000 and 2000–2001  133 (85.3)  23 (14.7) 
  2001–2002 and 2002–2003  229 (89.8)  26 (10.2) 
  2003–2004 and 2004–2005  228 (63.9)  129 (36.1) 
  2005–2006 and 2006–2007  253 (81.1)  59 (18.9) 
  2007–2008 and 2008–2009  302 (90.7)  31 (9.3) 
Sex
  M  642 (56.1)  145 (54.1) 
  F  503 (43.9)  122 (45.5) 
 Unknown  0  1  (0.4) 
Age group, y 
  <60  277 (24.2)  63 (23.5) 
 >60 866 (75.6)  193 (72) 
  Unknown  2 (0.2)  12 (4.5) 
Status
  Died  445 (38.9)  25 (9.3) 
  Did not die  664 (58)  159 (59.3) 
  Unknown  36 (3.1)  84 (31.3) 
*CQR, clinical questionnaire received. Human Listeriosis, England, 1999–2009
dence rates for certain conditions, they occurred relatively 
infrequently and were not used for treatments that could be 
prescribed for a range of conditions (e.g., broad-spectrum 
antimicrobial drugs).
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Table 2. Relative risks for ICD-10 conditions for case-patients with non–pregnancy-associated listeriosis, England, 1999–2009* 
Chapter and subgroup (code) 
Relative risk (95% CI) 
Versus other conditions  Age >60 y vs. <60 y
Certain infectious and parasitic diseases (A00–B99)  1.3 (0.9–2.0)  2.5 (1.1–5.9) 
Neoplasms (C00-D48)  4.9 (4.4–5.5)  2.9 (2.3–3.6) 
  Digestive organs (C15–C26)  3.1 (2.4–3.9)  NC 
  Respiratory and intrathoracic organs (C30–C39)  4.8 (3.5–6.5)  NC 
 Breast  (C50)  2.9 [2.1–4.1)  2.6 (1.4–5.2) 
  Female genital organs (C51–C58)  1.9 (1.07–3.5)  NC 
  Male genital organs (C60–C63)  2.9 (1.7–5.1)  NC 
  Eye, brain, and other parts of central nervous system (C69–C72)  7.3 (4.2–12.7)  NC 
  Thyroid and other endocrine glands (C73–C80, C97)  2.7 (2.0–3.6)  3.2 (1.6–6.4) 
  Lymphoid, hematopoietic, and related tissues (C81–C96)  17.6 (15.1–20.6)  2.8 (2.0–3.9) 
  In situ and benign neoplasms and others of uncertainty D00–D48)  0.7 (0.4–1.1)  NC 
Diseases of the blood and blood-forming organs and certain disorders involving the 
immune mechanism (D50–D89) 
1.3 (0.9–2.0)  0.8 (0.4–1.8) 
  Anemias (D50–D64)  1.0 (0.6–1.7)  NC 
  Diseases of blood and blood-forming organs (D65–D89)  2.3 (1.3–4.0)  NC 
Endocrine, nutritional and metabolic diseases (E00–E90)  5.3 (4.2–6.6)  6.3 (3.5–11.2) 
  Diabetes mellitus (E10–E14)  11.4 (9.0–14.5)  4.9 (2.7–8.8) 
Mental and behavior disorders (F00–F99)  3.1 (2.4–4.1)  1.7 (1.01–2.8) 
  Due to psychoactive substance (F10–F19)  12.3 (9.4–16.1)  4.7 (2.7–8.1) 
Diseases of the nervous system (G00–G99)  0.6 (0.4–1.0)  NC 
Diseases of the eye and adnexa (H00–H59)  NC  NC 
Diseases of the ear and mastoid process (H60–H95)  NC  NC 
Diseases of the circulatory system (I00–I99)  1.4 (1.2–1.6)  NC 
  Hypertensive diseases (I10–I15)  8.0 (5.2–12.2)  NC 
  Ischemic heart diseases (I20–I25)  0.8 (0.5–1.1)  NC 
  Other forms of heart disease (I30–I52)  2.4 (1.9–3.1)  NC 
  Cerebrovascular diseases (I60–I69)  0.7 (0.4–1.2)  NC 
  Diseases of arteries, arterioles, and capillaries (I70–I79) 2.1 (1.2–3.5)  NC 
Diseases of the respiratory system (J00–J99)  0.9 (0.7–1.1)  NC 
  Chronic lower respiratory diseases (J40–J47)  1.8 (1.3–2.5)  NC 
  Other diseases of respiratory system (J80–J99)  1.7 (0.95–3.1)  NC 
Diseases of the digestive system (K00–K93)  1.3 (1.1–1.5)  1.9 (1.4–2.6) 
  Noninfective enteritis and colitis (K50–K52)  4.3 (3.3–5.6)  2.3 (1.4–3.8) 
  Other diseases of intestines (K55–K63)  0.5 (0.3–0.9)  NC 
  Diseases of liver (K70–K77)  22.4 (17.7–28.4)  2.2 (1.4–3.6) 
Diseases of the skin and subcutaneous tissue (L00–L99)  NC  NC 
Diseases of the musculoskeletal system and connective tissue (M00–M99)  1.3 (1.1–1.6)  4.5 (2.7–7.3) 
  Arthropathies (M00–M25)  1.7 (1.3–2.2)  NC 
  Systemic connective tissue disorders (M30–M36)  18.3 (12.6–26.6)  NC 
Diseases of the genitourinary system (N00–N99)  1.2 (0.99–1.5)  5.3 (3.2–8.6) 
  Renal failure (N17–N19)  12.2 (9.8–15.1)  1.7 (1.02–2.7) 
Pregnancy, childbirth, and puerperium (O00–O99)  NC  NC 
Certain conditions originating in the perinatal period (P00–P96)  NC  NC 
Congenital malformations, deformations, and chromosomal abnormalities (Q00–Q99)  NC  NC 
Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere 
classified (R00–R99) 
NC NC 
Injury, poisoning, and certain other consequences of external causes (S00–T98)  NC  NC 
External causes of morbidity and mortality (V01–Y98)  – –
Factors influencing health status and contact with health services (Z00–Z99)  NC  NC 
Codes for special purposes (U00–U99)  – –
Total  NC 4.6 (4.1–5.3) 
*ICD-10, International Classification of Diseases, 10th Revision; CI, confidence interval; NC, not calculated (for conditions with <10 cases); –, data not 
available. RESEARCH
Because only single-variable analysis could be per-
formed, we could not assess the extent to which concurrent 
conditions were correlated, which led to the potential for 
uncontrolled confounding. Such method limitations might 
explain the high incidence associated with both diabetes 
and kidney disease and reinforce the need to consider these 
ﬁ  ndings as highly reﬁ  ned hypotheses to be tested by other 
methods (12).
To our knowledge, few studies have attempted to quan-
tify the risk for listeriosis by patient concurrent conditions. 
As part of a risk assessment of L. monocytogenes in ready-
to-eat foods, researchers from the World Health Organi-
zation (WHO) and the Food and Agriculture Organization 
(FAO) calculated the relative susceptibility to listeriosis for 
certain conditions (10). Furthermore, risk levels for listeri-
osis by predisposing condition in Denmark have also been 
estimated (11). Despite differences in methods between 
those studies and our study, several high-risk conditions 
were also identiﬁ  ed in those studies: malignancies (most 
notably those of the blood), kidney disease (recorded as di-
alysis [10] and renal transplant [11]), diabetes, alcoholism, 
and increased age in all 3 studies; liver disease and pul-
monary cancer in the WHO/FAO study and our study; and 
systemic lupus erythematosus in the study in Denmark and 
our study (as systemic connective tissue disorders). Such 
commonality would seemingly validate our estimates.
The absence of AIDS as a high-risk condition in our 
study and its presence in both previous studies (10,11), 
might reﬂ  ect improved treatment for HIV infection that 
prevents AIDS and, consequently, L. monocytogenes in-
fection (13) or highlight a reporting bias by the consultant 
microbiologist. A general transplantation status, identiﬁ  ed 
as a condition leading to the highest relative susceptibil-
ity in the WHO/FAO study, was not coded in our study 
because it is a treatment. Noninfective enteritis and colitis 
and certain diseases of the circulatory system were identi-
ﬁ  ed as additional high-risk conditions in our study but not 
in the previous studies. These additional conditions might 
be the result of improved accuracy, use of ICD-10 cod-
ing and a hospitalized reference population instead of the 
general population, different susceptibility calculations, or 
changes in the prevalence of certain conditions in the in-
terim period (the previous studies used data from 1992 [10] 
and 1989–1990 [11]). However, we acknowledge that links 
between these conditions and listeriosis have been reported 
(14–18).
With these caveats in mind, our ﬁ  ndings have implica-
tions for clinical practice and food safety policy makers. 
The number and diversity of conditions that appear to in-
crease the risk for listeriosis imply that physicians working 
in all specialties should consider listeriosis when treating 
patients with concurrent conditions and provide appropriate 
food safety advice. Similarly, current UK government food 
safety advice on avoidance of listeriosis, which is deliv-
ered passively and is speciﬁ  c mainly for pregnant women 
(19,20), should be communicated actively to all high-risk 
groups. In prioritizing advice, policy makers should con-
sider not only the associated risk but also the prevalence 
of the concurrent condition. Cancer patients accounted for 
more than one third of listeriosis cases, and high risks were 
observed for most cancer subgroups. Because we are not 
aware of any appropriate food safety advice that is tailored 
speciﬁ  cally for cancer patients in the UK, emphasis on this 
group might help to prevent further cases.
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